FindTrial
Sign In

Comparing Serum Interleukin 31 levels in patients of Chronic Spontaneous Urticaria and healthy controls and correlating it with the disease severity.

Comparison of Serum Interleukin 31 levels in Chronic Spontaneous Urticaria and healthy controls and its correlation with disease severity. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/06/069528
Enrollment
64
Registered
2024-06-26
Start date
Unknown
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L508- Other urticaria

Interventions

Control Intervention1: Nil: Nil

Sponsors

Dr Janice Reema Lewis
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with Chronic spontaneous Urticaria who agree to take part in the study. 2. Patients who do not have any comorbidities.

Exclusion criteria

Exclusion criteria: 1. Patients with coexisting conditions which show increased levels of IL 31 like atopic dermatitis, prurigo nodularis, psoriasis, bullous pemphigoid. 2. Patients on oral corticosteroids or other immunosuppressive drugs in the last 8 weeks or antihistamines atleast 4 days before the day of assessment. 3. Patients with any acute infection, immune complex disease, other autoimmune diseases.

Design outcomes

Primary

MeasureTime frame
1. To estimate the levels of Serum IL 31 in patients with Chronic spontaneous urticaria. 2. To compare serum IL 31 levels among patients with chronic spontaneous urticaria and healthy controls. 3. To determine the severity of chronic spontaneous urticaria. 4. To determine the correlation of serum IL 31 levels with the severity of chronic spontaneous urticaria.Timepoint: At Baseline.—

Secondary

MeasureTime frame
NilTimepoint: Nil—

Countries

India

Contacts

Public ContactJanice Reema Lewis

Father Muller Medical College

michelle@fathermuller.in9980785447

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026